Terms: = Ovarian cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
20 results:
1. Mature cystic ovarian teratoma with squamous cell carcinoma transformation: a case report and literature review.
Abdoli Shadbad M; Derogar R; Shekarchi AA; Akbari F; Jafari Shobeiri M
Horm Mol Biol Clin Investig; 2024 Mar; 45(1):35-39. PubMed ID: 38282269
[TBL] [Abstract] [Full Text] [Related]
2. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
3. Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma.
Sia TY; Huang Y; Gockley A; Melamed A; Khoury-Collado F; St Clair C; Hou JY; Tergas AI; Hershman DL; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):734-740. PubMed ID: 33810881
[TBL] [Abstract] [Full Text] [Related]
4. Frizzled-7 Identifies Platinum-Tolerant ovarian cancer Cells Susceptible to Ferroptosis.
Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
[TBL] [Abstract] [Full Text] [Related]
5. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
Brett MA; Atenafu EG; Singh N; Ghatage P; Clarke BA; Nelson GS; Bernardini MQ; Köbel M
Int J Gynecol Pathol; 2021 Mar; 40(2):116-123. PubMed ID: 32265358
[TBL] [Abstract] [Full Text] [Related]
6. Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast cancer.
Kietzman WB; Graham GT; Ory V; Sharif GM; Kushner MH; Gallanis GT; Kallakury B; Wellstein A; Riegel AT
Mol Cancer Ther; 2019 Dec; 18(12):2220-2232. PubMed ID: 31451564
[TBL] [Abstract] [Full Text] [Related]
7. Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant ovarian cancer Cells.
Park GB; Jeong JY; Kim D
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31336860
[TBL] [Abstract] [Full Text] [Related]
8. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract] [Full Text] [Related]
9. The role of immunohistochemical examination in diagnosis of papillary thyroid cancer in struma ovarii.
Szczepanek-Parulska E; Pioch A; Cyranska-Chyrek E; Wolinski K; Jarmołowska-Jurczyszyn D; Janicka-Jedynska M; Majewski P; Zabel M; Ruchala M
Folia Histochem Cytobiol; 2019; 57(1):35-42. PubMed ID: 30924920
[TBL] [Abstract] [Full Text] [Related]
10. Squamous carcinoma coexistent with teratoma of ovary: a clinicopathological study of 12 cases diagnosed over a 10-year period at a tertiary cancer referral center.
Rekhi B; Parikh P; Deodhar KK; Menon S; Maheshwari A; Kerkar R; Gupta S
J Cancer Res Ther; 2015; 11(1):211-5. PubMed ID: 25879364
[TBL] [Abstract] [Full Text] [Related]
11. CA125 expression in the tissue of uterine leiomyosarcoma.
Menczer J; Schreiber L; Berger E; Ben-Shem E; Golan A; Levy T
Isr Med Assoc J; 2014 Nov; 16(11):697-9. PubMed ID: 25558698
[TBL] [Abstract] [Full Text] [Related]
12. Tumor suppressor genes associated with drug resistance in ovarian cancer (review).
Yin F; Liu X; Li D; Wang Q; Zhang W; Li L
Oncol Rep; 2013 Jul; 30(1):3-10. PubMed ID: 23660957
[TBL] [Abstract] [Full Text] [Related]
13. Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.
Trinh XB; Tjalma WA; Dirix LY; Vermeulen PB; Peeters DJ; Bachvarov D; Plante M; Berns EM; Helleman J; Van Laere SJ; van Dam PA
PLoS One; 2011; 6(7):e22469. PubMed ID: 21799864
[TBL] [Abstract] [Full Text] [Related]
14. PPARγ ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells.
Kim S; Lee JJ; Heo DS
Biochem Biophys Res Commun; 2011 Mar; 406(3):389-95. PubMed ID: 21329655
[TBL] [Abstract] [Full Text] [Related]
15. An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma.
Miller K; Price JH; Dobbs SP; McClelland RH; Kennedy K; McCluggage WG
J Clin Pathol; 2008 May; 61(5):652-7. PubMed ID: 18006668
[TBL] [Abstract] [Full Text] [Related]
16. Primary leiomyosarcoma of the fallopian tube: a case report.
Mariani L; Quattrini M; Galati M; Dionisi B; Piperno G; Modafferi F; Sbiroli C
Eur J Gynaecol Oncol; 2005; 26(3):333-5. PubMed ID: 15991540
[TBL] [Abstract] [Full Text] [Related]
17. Primary ovarian leiomyosarcoma. Proliferation rate and survival.
Nicòtina PA; Antico F; Caruso C; Triolo O
Eur J Gynaecol Oncol; 2004; 25(4):515-6. PubMed ID: 15285319
[TBL] [Abstract] [Full Text] [Related]
18. Why did p53 gene therapy fail in ovarian cancer?
Zeimet AG; Marth C
Lancet Oncol; 2003 Jul; 4(7):415-22. PubMed ID: 12850192
[TBL] [Abstract] [Full Text] [Related]
19. Primary sarcoma of the ovary: report of five cases and review of the literature.
Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
Eur J Gynaecol Oncol; 1998; 19(3):257-61. PubMed ID: 9641226
[TBL] [Abstract] [Full Text] [Related]
20. Different types and different prognosis-study of 310 uterine sarcomas.
Nickie-Psikuta M; Gawrychowski K
Eur J Gynaecol Oncol; 1993; 14 Suppl():105-13. PubMed ID: 8200360
[TBL] [Abstract] [Full Text] [Related]
